Furiex Pharmaceuticals, Inc. 4/A
4/A · Furiex Pharmaceuticals, Inc. · Filed Sep 18, 2013
Insider Transaction Report
Form 4/AAmended
McIntyre Gail Frances
Senior Vice President-Research
Transactions
- Sale
Common Stock
2013-07-19$40.00/sh−20,000$800,000→ 17,868 total
Footnotes (1)
- [F1]This sale was pursuant to a Rule 10b5-1 Sales Plan, which is intended to comply with Rule 10b5-1.